Metriport vs Particle Health
Updated October 16, 2026
Digital health teams that need a patient's outside records often choose between Metriport and Particle Health. Both pull records from national exchange networks through one API, but Metriport publishes its code as open source, while Particle has been selling network access longer and leans on its record condensing tools. Engineering-led startups and established care teams can reach opposite conclusions here.
Our analysts compared Metriport and Particle Health on record access, product scope, open-source code, integration effort, pricing, and track record, using the HIR review of each company and Metriport's newsroom. In the following sections, we compare the two networks, describe the team each fits, and note Metriport's progress this year.
Metriport vs Particle Health at a glance, October 2026
| What buyers weigh | Metriport | Particle Health |
|---|---|---|
| Pricing model | Usage-based platform pricing quoted by Metriport, scaled by patients and data services. | Platform and usage contracts tied to network access and how you run lookups. |
| What drives cost | Number of patients looked up, how many admission and discharge alerts you get, and add-ons such as AI summaries, care gaps, and EHR apps. | How many records you pull, environments, and services to get your first uses live. |
| Getting usable outside records | Metriport scores 7.2 for records access, delivering each patient's data as one record in FHIR, the standard format for exchanging health data. | Particle scores 7.6, with the best results when retrieved charts feed a live workflow such as intake or care management. Higher score |
| Network and API product | Data arrives through an API, a data warehouse, EHR apps, or an embedded dashboard. | Particle retrieves records across the network and condenses long histories into something a care team can use. Clear edge |
| Open-source code | Engineers can read Metriport's open-source code before the company signs a contract. Clear edge | Particle's API is commercial software without public source code. |
| Getting the integration live | One integration gets a team connected, and it needs engineers who can work with an API. Clear edge | Production use needs a security review, checks on how well patients are matched, and ongoing data-quality work. |
| Track record | Metriport was founded in 2021 and in August 2026 listed Amazon One Medical, Sollis Health, and Color Health as customers. | Particle Health, founded in 2018, has the longer record of the two with customers. Clear edge |
| Time to full value | About 8 to 16 weeks | About 5 to 11 months |
| What you need first | Engineers assigned to the integration. | A real use that needs records from outside providers. |
| Deal-breaker | You have no engineers. | You only need one direct EHR interface (the wrong kind of tool). |
| Pricing clarity score | 7.0 | 7.2 |
| HIR overall score | 7.2, Recommend. | 7.4, Recommend. |
| Best for | Digital health companies and startups that want outside records through one API. | Digital health and mid-market providers that need longitudinal records through a clinical data network. |
| Not a fit for | Health systems that want a long-established vendor with many years of references. | Teams without privacy, BAA, and data-governance bandwidth. |
Which fits which buyer
Think about who will maintain the integration.
Choose Metriport if
- Your engineers want to read the code before signing.
- You want records as one FHIR record per patient through a single integration.
- You like a vendor moving toward direct participation in TEFCA.
Choose Particle Health if
- You want a vendor with a longer customer history.
- Retrieved charts will feed intake or care management right away.
- You want long histories condensed for clinicians.
Verdict
Particle scores higher and suits teams that value a longer track record and polished record summaries. Metriport suits engineering-led startups that want open code and a single integration.
Both need a team ready to handle privacy agreements and data governance.
Where the two tools are headed in 2027 and beyond
Metriport: Metriport announced new funding on August 27, 2026, and on September 17, 2026 said it had been accepted as a candidate QHIN under TEFCA.
Test patient match rates on a sample of your own records before you sign.
Methodology
Each row comes from the HIR reviews of Metriport and Particle Health, scored under the HIR method, and from each vendor's public pricing where it exists. Any published price for Metriport or Particle Health was checked on that vendor's own site on October 16, 2026.
A green check marks a clear edge for Metriport or Particle Health only where their review scores differ by at least 0.3 points or the two reviews show a plain difference. Rows with nothing published for either Metriport or Particle Health are left out, and time to full value for each adds up the rollout stages in its review.
Sources
- HIR review of Metriport and HIR review of Particle Health
- Metriport website
- Particle Health website
- Metriport Series A, August 27, 2026
- Metriport candidate QHIN, September 17, 2026